Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Argentum Pharmaceuticals and Eli Lilly Settle Patent Dispute Over CIALIS®
Wednesday, August 23, 2017Argentum Pharmaceuticals LLC a generic pharmaceutical company announced that it has reached a settlement and license agreement with Eli Lilly and Company related to Argentums generic version of CIALIS tadalifil The agreement generally provides tha...
PharmAkea Announces Successful Completion of a Phase 1 Trial in Healthy Subjects For Its Novel LOXL2 Inhibitor, PAT-1251
Wednesday, August 23, 2017PharmAkea Inc announced that it has successfully completed a Phase single and multiple ascending dose SADMAD clinical study with PAT its novel smallmolecule LOXL inhibitor being developed for the treatment of IPF and other fibrotic diseases The s...
Syros Receives FDA Orphan Drug Designation for SY-1425 for Treatment of AML
Tuesday, August 22, 2017Syros Pharmaceuticals a biopharmaceutical company pioneering the discovery and development of medicines to control the expression of diseasedriving genes today announced that the US Food and Drug Administration FDA has granted orphan drug designation...
PAREXEL and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan
Tuesday, August 22, 2017PAREXEL International Corporation a leading global biopharmaceutical services provider and Osaka International Cancer Institute today announced that they have formed an alliance to advance clinical development in Japan The partnership will aim to dri...
MiMedx Signs Definitive Agreement to Divest Stability Biologics Subsidiary as Part of Company's Strategic Focus on Biopharma
Monday, August 21, 2017MiMedx Group Inc the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patentprotected processes for multiple sectors of healthcare announced today that i...
Samsung Bioepis and Takeda Sign Strategic Collaboration Agreement
Monday, August 21, 2017Samsung Bioepis Co Ltd announced today that it has entered into a strategic collaboration agreement with Takeda Pharmaceutical Company Limited TSE to jointly fund and codevelop multiple novel biologic therapies in unmet disease areas The two compani...
Teva Announces Exclusive Launch of Generic Axiron® in the United States
Saturday, August 19, 2017Teva Pharmaceutical Industries Ltd today announced the launch of generic Axiron testosterone topical solution CIII mg mL in the US Testosterone topical solution CIII is a prescription medicine used to treat adult males who have low or no testoste...
Medivir Licenses Exclusive Rights to MIV-802 for Greater China to Ascletis
Saturday, August 19, 2017Medivir AB and Ascletis today announce that Ascletis has licensed the exclusive rights to develop manufacture and commercialize Medivirs nucleotide polymerase inhibitor for hepatitis C MIV Ascletis code ASC in Greater China Under the terms of the...
BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub
Friday, August 18, 2017BlueRock Therapeutics which is developing cellbased therapies designed to alter the course of degenerative disease today announces the expansion of the companys presence in Toronto with a research development and manufacturing site in the MaRS Discov...
Hikma Announces New Licensing Agreement With Takeda
Friday, August 18, 2017Hikma Pharmaceuticals PLC the multinational pharmaceutical group today announces that through its wholly owned subsidiary Hikma Pharmaceuticals LLC it has agreed to expand its licensing and distribution agreement with Takeda Pharmaceutical Company Li...
